🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
Last 30 Days
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(2267)
All (2267)
Buys (212)
Sells (2055)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
Oruka Therapeutics, Inc.
(ORKA)
Goncalves Joana
— Chief Medical Officer
Mar 16, 2026
Sale
Shares
2,902
Price
$41.20
Total Value
$119.57K
Shares Held After
35,195
% of Holdings
7.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Oruka Therapeutics, Inc.
(ORKA)
Goncalves Joana
— Chief Medical Officer
Mar 16, 2026
Sale
Shares
2,921
Price
$40.11
Total Value
$117.16K
Shares Held After
38,097
% of Holdings
7.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Oruka Therapeutics, Inc.
(ORKA)
Agarwal Arjun
— Senior Vice President, Finance
Mar 16, 2026
Sale
Shares
395
Price
$41.30
Total Value
$16.31K
Shares Held After
18,863
% of Holdings
2.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Oruka Therapeutics, Inc.
(ORKA)
Sandler Laura Lee
— Chief Operating Officer
Mar 16, 2026
Sale
Shares
600
Price
$41.30
Total Value
$24.78K
Shares Held After
236,984
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Fortrea Holdings Inc.
(FTRE)
Morais Mark A.
— Chief Operating Officer
Mar 16, 2026
Sale
Shares
1,804
Price
$9.22
Total Value
$16.63K
Shares Held After
69,899
% of Holdings
2.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Oruka Therapeutics, Inc.
(ORKA)
Klein Lawrence Otto
— Director
Mar 16, 2026
Sale
Shares
1,729
Price
$41.30
Total Value
$71.41K
Shares Held After
927,309
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Mirum Pharmaceuticals, Inc.
(MIRM)
Peetz Christopher
— Director
Mar 16, 2026
Sale
Shares
40,985
Price
$91.98
Total Value
$3.77M
Shares Held After
194,309
% of Holdings
17.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Mirum Pharmaceuticals, Inc.
(MIRM)
Quan Joanne
— CHIEF MEDICAL OFFICER
Mar 16, 2026
Sale
Shares
7,287
Price
$91.98
Total Value
$670.24K
Shares Held After
18,864
% of Holdings
27.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Mirum Pharmaceuticals, Inc.
(MIRM)
Howe Jolanda
— SVP, GLOBAL CONTROLLER
Mar 16, 2026
Sale
Shares
4,732
Price
$91.98
Total Value
$435.24K
Shares Held After
8,429
% of Holdings
36.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Mirum Pharmaceuticals, Inc.
(MIRM)
Ramasastry Saira
— Director
Mar 16, 2026
Sale
Shares
2,000
Price
$90.76
Total Value
$181.52K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Mirum Pharmaceuticals, Inc.
(MIRM)
Radovich Peter
— PRESIDENT AND COO
Mar 16, 2026
Sale
Shares
16,515
Price
$91.98
Total Value
$1.52M
Shares Held After
40,272
% of Holdings
29.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Mirum Pharmaceuticals, Inc.
(MIRM)
BJERKHOLT ERIC
— CHIEF FINANCIAL OFFICER
Mar 16, 2026
Sale
Shares
7,287
Price
$91.98
Total Value
$670.24K
Shares Held After
49,788
% of Holdings
12.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
iRhythm Holdings, Inc.
(IRTC)
Smith Mervin
— EVP Strategic Business Ops
Mar 16, 2026
Sale
Shares
2,585
Price
$114.30
Total Value
$295.47K
Shares Held After
23,027
% of Holdings
10.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Guardant Health, Inc.
(GH)
Bell Michael Brian
— Chief Financial Officer
Mar 16, 2026
Sale
Shares
3,000
Price
$87.04
Total Value
$261.11K
Shares Held After
43,601
% of Holdings
6.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GILEAD SCIENCES, INC.
(GILD)
Mercier Johanna
— Chief Comm & Corp Aff Officer
Mar 16, 2026
Sale
Shares
3,000
Price
$144.23
Total Value
$432.69K
Shares Held After
131,779
% of Holdings
2.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CASTLE BIOSCIENCES INC
(CSTL)
MAETZOLD DEREK J
— Director
Mar 16, 2026
Sale
Shares
126
Price
$26.68
Total Value
$3.36K
Shares Held After
40,779
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CASTLE BIOSCIENCES INC
(CSTL)
MAETZOLD DEREK J
— Director
Mar 16, 2026
Sale
Shares
17,449
Price
$25.96
Total Value
$453.05K
Shares Held After
40,905
% of Holdings
29.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Upstream Bio, Inc.
(UPB)
Ambrose Allison
— General Counsel
Mar 16, 2026
Sale
Shares
475
Price
$9.29
Total Value
$4.41K
Shares Held After
16,525
% of Holdings
2.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Upstream Bio, Inc.
(UPB)
Sutherland Everett Rand
— Director
Mar 16, 2026
Sale
Shares
2,093
Price
$9.29
Total Value
$19.44K
Shares Held After
72,907
% of Holdings
2.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Terns Pharmaceuticals, Inc.
(TERN)
Burroughs Amy L.
— Director
Mar 16, 2026
Sale
Shares
2,770
Price
$47.30
Total Value
$131.03K
Shares Held After
288,976
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Terns Pharmaceuticals, Inc.
(TERN)
Burroughs Amy L.
— Director
Mar 16, 2026
Sale
Shares
11,813
Price
$46.57
Total Value
$550.08K
Shares Held After
291,746
% of Holdings
3.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GILEAD SCIENCES, INC.
(GILD)
Dickinson Andrew D
— Chief Financial Officer
Mar 16, 2026
Sale
Shares
3,000
Price
$144.23
Total Value
$432.69K
Shares Held After
179,191
% of Holdings
1.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Upstream Bio, Inc.
(UPB)
Deykin Aaron
— Chief Medical Officer
Mar 16, 2026
Sale
Shares
894
Price
$9.29
Total Value
$8.31K
Shares Held After
32,687
% of Holdings
2.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Upstream Bio, Inc.
(UPB)
GRAY MICHAEL
— CFO and COO
Mar 16, 2026
Sale
Shares
852
Price
$9.29
Total Value
$7.92K
Shares Held After
29,648
% of Holdings
2.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MYOMO, INC.
(MYO)
Getz Heather C
— Director
Mar 16, 2026
Purchase
Shares
20,000
Price
$0.70
Total Value
$13.97K
Shares Held After
131,754
% of Holdings
15.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CRISPR Therapeutics AG
(CRSP)
Kulkarni Samarth
— Director
Mar 16, 2026
Sale
Shares
10,349
Price
$48.26
Total Value
$499.44K
Shares Held After
245,834
% of Holdings
4.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CRISPR Therapeutics AG
(CRSP)
Prasad Raju
— Chief Financial Officer
Mar 16, 2026
Sale
Shares
4,021
Price
$48.26
Total Value
$194.05K
Shares Held After
13,773
% of Holdings
22.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CRISPR Therapeutics AG
(CRSP)
Prasad Raju
— Chief Financial Officer
Mar 16, 2026
Sale
Shares
5,848
Price
$48.26
Total Value
$282.22K
Shares Held After
17,794
% of Holdings
24.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CRISPR Therapeutics AG
(CRSP)
KASINGER JAMES R.
— General Counsel and Secretary
Mar 16, 2026
Sale
Shares
3,450
Price
$48.26
Total Value
$166.50K
Shares Held After
91,240
% of Holdings
3.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CRISPR Therapeutics AG
(CRSP)
Patel Naimish
— Chief Medical Officer
Mar 16, 2026
Sale
Shares
3,150
Price
$48.26
Total Value
$152.02K
Shares Held After
13,143
% of Holdings
19.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Bicara Therapeutics Inc.
(BCAX)
Cohlhepp Ryan
— Director
Mar 16, 2026
Sale
Shares
4,500
Price
$19.66
Total Value
$88.46K
Shares Held After
200,641
% of Holdings
2.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Bicara Therapeutics Inc.
(BCAX)
Cohlhepp Ryan
— Director
Mar 16, 2026
Sale
Shares
8,000
Price
$19.66
Total Value
$157.26K
Shares Held After
205,141
% of Holdings
3.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 16, 2026
Sale
Shares
160
Price
$537.37
Total Value
$85.98K
Shares Held After
40,513
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 16, 2026
Sale
Shares
763
Price
$536.49
Total Value
$409.34K
Shares Held After
40,673
% of Holdings
1.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 16, 2026
Sale
Shares
1,551
Price
$535.59
Total Value
$830.70K
Shares Held After
41,436
% of Holdings
3.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 16, 2026
Sale
Shares
1,779
Price
$534.47
Total Value
$950.82K
Shares Held After
42,987
% of Holdings
4.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 16, 2026
Sale
Shares
2,526
Price
$533.65
Total Value
$1.35M
Shares Held After
44,766
% of Holdings
5.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 16, 2026
Sale
Shares
1,597
Price
$532.66
Total Value
$850.66K
Shares Held After
47,292
% of Holdings
3.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 16, 2026
Sale
Shares
564
Price
$531.69
Total Value
$299.87K
Shares Held After
48,889
% of Holdings
1.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 16, 2026
Sale
Shares
200
Price
$530.73
Total Value
$106.15K
Shares Held After
49,453
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 16, 2026
Sale
Shares
360
Price
$529.16
Total Value
$190.50K
Shares Held After
49,653
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alignment Healthcare, Inc.
(ALHC)
Maroney Dawn Christine
— President
Mar 16, 2026
Sale
Shares
30,000
Price
$17.48
Total Value
$524.43K
Shares Held After
1,095,562
% of Holdings
2.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Upstream Bio, Inc.
(UPB)
Houghton Adam
— Chief Business Officer
Mar 16, 2026
Sale
Shares
699
Price
$9.29
Total Value
$6.49K
Shares Held After
24,301
% of Holdings
2.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CG Oncology, Inc.
(CGON)
Mulay James
— Director
Mar 16, 2026
Sale
Shares
1,310
Price
$63.50
Total Value
$83.19K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CG Oncology, Inc.
(CGON)
Mulay James
— Director
Mar 16, 2026
Sale
Shares
654
Price
$63.50
Total Value
$41.53K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ORTHOPEDIATRICS CORP
(KIDS)
Hauser Joseph W
— Pres. Trauma & Def. Correction
Mar 16, 2026
Sale
Shares
8,596
Price
$17.25
Total Value
$148.28K
Shares Held After
194,767
% of Holdings
4.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ORTHOPEDIATRICS CORP
(KIDS)
Hite Fred
— Director
Mar 16, 2026
Sale
Shares
12,993
Price
$17.25
Total Value
$224.13K
Shares Held After
277,477
% of Holdings
4.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ORTHOPEDIATRICS CORP
(KIDS)
Bailey David R
— Director
Mar 16, 2026
Sale
Shares
19,535
Price
$17.25
Total Value
$336.98K
Shares Held After
298,020
% of Holdings
6.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ORTHOPEDIATRICS CORP
(KIDS)
Odle Gregory A
— President of Scoliosis
Mar 16, 2026
Sale
Shares
8,433
Price
$17.25
Total Value
$145.47K
Shares Held After
187,735
% of Holdings
4.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ORTHOPEDIATRICS CORP
(KIDS)
Gerritzen Daniel J
— General Counsel and Secretary
Mar 16, 2026
Sale
Shares
8,614
Price
$17.25
Total Value
$148.59K
Shares Held After
149,533
% of Holdings
5.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 451–500 of 2267 transactions (page 10 of 46)
Version: v26.3.33